p21-activated kinases as viable therapeutic targets for the treatment of high-risk Ewing sarcoma.
Qasim SL, Sierra L, Shuck R, Kurenbekova L, Patel TD, Rajapakshe K, Wulff J, Nakahata K, Kim HR, Landesman Y, Unger TJ, Coarfa C, Yustein JT.
Qasim SL, et al. Among authors: wulff j.
Oncogene. 2021 Feb;40(6):1176-1190. doi: 10.1038/s41388-020-01600-9. Epub 2021 Jan 7.
Oncogene. 2021.
PMID: 33414491